Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CDMO

Avid Bioservices (CDMO) Stock Price, News & Analysis

Avid Bioservices logo

About Avid Bioservices Stock (NASDAQ:CDMO)

Advanced Chart

Key Stats

Today's Range
$12.47
$12.51
50-Day Range
$12.50
$12.50
52-Week Range
$8.05
$12.51
Volume
3.07 million shs
Average Volume
1.45 million shs
Market Capitalization
$799.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.25
Consensus Rating
Hold

Company Overview

Avid Bioservices Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
12th Percentile Overall Score

CDMO MarketRank™: 

Avid Bioservices scored higher than 12% of companies evaluated by MarketBeat, and ranked 888th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Avid Bioservices has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Avid Bioservices has received no research coverage in the past 90 days.

  • Read more about Avid Bioservices' stock forecast and price target.
  • Earnings Growth

    Earnings for Avid Bioservices are expected to grow in the coming year, from ($0.46) to ($0.23) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Avid Bioservices is -5.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Avid Bioservices is -5.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Avid Bioservices has a P/B Ratio of 4.14. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Avid Bioservices' valuation and earnings.
  • Short Interest

    There is no current short interest data available for CDMO.
  • Dividend Yield

    Avid Bioservices does not currently pay a dividend.

  • Dividend Growth

    Avid Bioservices does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CDMO.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Avid Bioservices this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Avid Bioservices insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.05% of the stock of Avid Bioservices is held by insiders.

  • Percentage Held by Institutions

    97.16% of the stock of Avid Bioservices is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Avid Bioservices' insider trading history.
Receive CDMO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avid Bioservices and its competitors with MarketBeat's FREE daily newsletter.

CDMO Stock News Headlines

TEHN.BE,0P0000CK2E,0 (TEHN.BE)
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.
Avid Bioservices launches new company website design
See More Headlines

CDMO Stock Analysis - Frequently Asked Questions

Avid Bioservices, Inc. (NASDAQ:CDMO) released its earnings results on Tuesday, December, 10th. The biopharmaceutical company reported ($0.27) earnings per share for the quarter, missing analysts' consensus estimates of ($0.13) by $0.14. Avid Bioservices had a negative trailing twelve-month return on equity of 33.18% and a negative net margin of 101.07%.

Avid Bioservices shares reverse split before market open on Monday, July 10th 2017.The 1-7 reverse split was announced on Friday, July 7th 2017. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 7th 2017. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avid Bioservices investors own include American Water Works (AWK), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY) and Humana (HUM).

Company Calendar

Last Earnings
12/10/2024
Today
7/12/2025
Next Earnings (Estimated)
9/08/2025
Fiscal Year End
4/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CDMO
CIK
704562
Employees
320
Year Founded
N/A

Price Target and Rating

High Price Target
$12.50
Low Price Target
$12.00
Potential Upside/Downside
-2.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.39)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$140.75 million
Net Margins
-101.07%
Pretax Margin
N/A
Return on Equity
-33.18%
Return on Assets
-8.45%

Debt

Debt-to-Equity Ratio
3.58
Current Ratio
1.30
Quick Ratio
0.92

Sales & Book Value

Annual Sales
$139.91 million
Price / Sales
5.71
Cash Flow
$0.15 per share
Price / Cash Flow
80.92
Book Value
$3.02 per share
Price / Book
4.14

Miscellaneous

Outstanding Shares
63,960,000
Free Float
62,012,000
Market Cap
$799.18 million
Optionable
Optionable
Beta
1.39

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:CDMO) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners